Mirxes Holding Forms Strategic Partnership with N Health to Launch Cancer Screening in Thailand

Reuters01-09
Mirxes Holding Forms Strategic Partnership with N Health to Launch Cancer Screening in Thailand

Mirxes Holding Company Limited has announced the signing of a strategic partnership with N Health, a healthcare solutions provider and member of the Bangkok Dusit Medical Services (BDMS) Group, Thailand's largest healthcare provider. The collaboration aims to introduce Mirxes' advanced microRNA (miRNA) cancer screening solutions, including GASTROClear™ for gastric cancer and LUNGClear™ for lung cancer, across nearly 60 hospitals within N Health's network. This partnership is expected to enhance early cancer detection and improve patient outcomes in Thailand and the wider Southeast Asian region, supporting broader access to early disease detection and contributing to improved standards of cancer care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260109-11986411), on January 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment